Manufacturing Advances Unlock The Therapeutic Potential Of MSC-Derived Exosomes

Exosomes / Extracellular Vesicles (EVs) are an emerging class of biologics that play a crucial role in cellular communication. Their tremendous promise has increased the number of researchers and product developers exploring an array of therapeutic endpoints that will require consistent scalable manufacturing to bolster these programs as they move toward clinical implementation.

Explore how RoosterBio is Transforming MSC and EV Production and how you can overcoming challenges in the process through customization. Also covered in this webinar is an explanation of how bone marrow-MSC EVs with anti-inflammatory activity are being used for the treatment of retinal degeneration and traumatic brain injuries.